A carregar...

Targeting norepinephrine in mild cognitive impairment and Alzheimer's disease

The Alzheimer's disease (AD) epidemic is a looming crisis, with an urgent need for new therapies to delay or prevent symptom onset and progression. There is growing awareness that clinical trials must target stage-appropriate pathophysiological mechanisms to effectively develop disease-modifyin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Chalermpalanupap, Termpanit, Kinkead, Becky, Hu, William T, Kummer, Markus P, Hammerschmidt, Thea, Heneka, Michael T, Weinshenker, David, Levey, Allan I
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3706916/
https://ncbi.nlm.nih.gov/pubmed/23634965
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/alzrt175
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!